---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-048576"
form_type: "8-K"
ticker: "BCYC"
cik: "0001761612"
company_name: "BICYCLE THERAPEUTICS PLC"
filed_at: "2024-04-18T23:59:59+00:00"
generated_at: "2026-06-03T19:12:06.499163+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bicycle Therapeutics appoints Felix Baker to board; Jordan resigns, becomes consultant

## Summary
- Veronica Jordan resigned as director April 17; will serve as consultant at GBP 12,000/yr for 2-year term, equity continues vesting.
- Felix J. Baker appointed as Class I director effective April 18; will sit on Nominating and Scientific committees.
- BBA Funds (Baker's affiliates) obtained registration rights for resale of ordinary shares/ADSs; company to file registration within 60 days of demand.
- BBA Funds hold >10% of outstanding shares; Baker is a managing member of Baker Bros. Advisors GP.

## SEC filing metadata
- accession: 0001104659-24-048576
- form_type: 8-K
- ticker: BCYC
- cik: 0001761612
- company_name: BICYCLE THERAPEUTICS PLC
- filed_at: 2024-04-18T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/0001104659-24-048576-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/tm2412008d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-048576
- JSON: https://secwatch.observer/filing/0001104659-24-048576.json
- Plain text: https://secwatch.observer/filing/0001104659-24-048576.txt

## Key facts
- Executive change
  Felix J. Baker was appointed as Class I Director at BICYCLE THERAPEUTICS PLC.
  - Action: appointed
  - Role: Class I Director
  source text: On April 16, 2024, the Board , upon the recommendation of the Nominating and Corporate Governance Committee of the Company (the “ NCGC ”), appointed Felix J. Baker, Ph.D. to the Board, effective as of April 18, 2024, New York City time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/0001104659-24-048576-index.htm
- Executive change
  Veronica Jordan resigned as Class I Director at BICYCLE THERAPEUTICS PLC.
  - Action: resigned
  - Role: Class I Director
  source text: On April 16, 2024, Veronica Jordan, Ph.D. notified the Board of Directors of the Company (the “ Board ”) of her decision to resign as a Class I director of the Company and as the Chair of the Compensation Committee of the Board and as a member of the Audit Committee of the Board, effective as of the close of business on April 17, 2024, New York City time.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1761612/000110465924048576/0001104659-24-048576-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.